```html

Wheals (Urticaria)

What is Wheals (Urticaria)?

Wheals—commonly called hives—are raised, red or skin‑colored, itchy plaques that appear on the surface of the skin. The medical term for this condition is urticaria. A wheal typically begins as a small, itchy spot that expands quickly (often within minutes) to form a disc‑shaped plaque with a pale center and a reddened border. Most wheals are transient, disappearing within 24 hours, although new lesions may continue to develop for days or weeks.

Urticaria can be classified in several ways:

• Acute urticaria: lasts < 6 weeks; most often triggered by an infection, medication, or food allergy.
• Chronic urticaria: persists ≥ 6 weeks; may be autoimmune or idiopathic.
• Physical urticarias: induced by physical stimuli such as cold, heat, pressure, vibration, or sunlight.
• Angio‑edema: swelling of deeper layers of the skin or mucous membranes that often accompanies wheals.

Although wheals are usually harmless, they can be uncomfortable and, in rare cases, herald a serious allergic reaction (anaphylaxis). Understanding the underlying cause is key to effective management.

Common Causes

Urticaria is a symptom, not a disease itself. Below are the most frequent triggers identified in clinical practice and research:

• Allergic reactions to foods: nuts, shellfish, eggs, milk, soy, and certain fruits (e.g., strawberries, kiwi).
• Medications: antibiotics (especially penicillins and sulfonamides), non‑steroidal anti‑inflammatory drugs (NSAIDs), aspirin, and certain vaccines.
• Infections: viral (e.g., hepatitis, Epstein‑Barr, COVID‑19), bacterial (e.g., streptococcal pharyngitis), or parasitic infections.
• Physical stimuli (physical urticarias): cold exposure, heat, pressure (dermographism), sunlight (solar urticaria), water (aquagenic urticaria), or exercise.
• Autoimmune disease: chronic spontaneous urticaria can be driven by auto‑antibodies against the high‑affinity IgE receptor (IgE‑FcεRI) or IgE itself.
• Hormonal changes: menstrual cycle fluctuations, pregnancy, or thyroid disease.
• Stress and emotional factors: acute stress can precipitate or exacerbate urticaria episodes.
• Contact irritants: latex, fragrances, cleaning chemicals, or certain metals (e.g., nickel).
• Underlying systemic diseases: lymphoma, hepatitis, HIV, or systemic lupus erythematosus can present with chronic urticaria.
• Idiopathic: up to 50 % of chronic cases have no identifiable trigger despite thorough evaluation.

Associated Symptoms

Because wheals are a cutaneous manifestation of mast‑cell degranulation, they frequently coexist with other signs of histamine release:

• Intense itching (pruritus) – often the most bothersome symptom.
• Burning or stinging sensation under the wheal.
• Swelling of lips, eyelids, hands, or feet (angio‑edema).
• Redness or flushing of the surrounding skin.
• Gastrointestinal upset (nausea, abdominal pain) if the trigger is an ingested allergen.
• Respiratory symptoms (hoarseness, throat tightness, wheezing) – especially when urticaria is part of anaphylaxis.
• Low‑grade fever or malaise in infection‑related urticaria.

When to See a Doctor

Most acute wheals resolve on their own, but you should seek medical attention if you notice any of the following:

• Wheals persist longer than 24 hours or keep re‑appearing for more than 6 weeks.
• Severe itching that interferes with sleep or daily activities.
• Swelling of the face, lips, tongue, or throat (possible angio‑edema).
• Difficulty breathing, wheezing, or a feeling of throat tightening.
• Rapid spread of hives after starting a new medication or food.
• Fever, joint pain, or unexplained weight loss accompanying chronic hives.
• Pregnancy, breastfeeding, or known autoimmune disease—these conditions may require special management.

Diagnosis

Diagnosing urticaria involves a combination of history, physical exam, and targeted testing.

1. Detailed History

• Onset, duration, and pattern of lesions.
• Recent exposures: foods, drugs, insect bites, physical activities, stressors.
• Family or personal history of allergies, asthma, or autoimmune disease.
• Associated systemic symptoms.

2. Physical Examination

• Inspection of wheal size, shape, and distribution.
• Assessment for angio‑edema, dermographism (stroke the skin with a blunt object to see if a wheal forms), or signs of systemic illness.

3. Laboratory & Allergy Testing

• Complete blood count (CBC): eosinophilia may suggest an allergic cause.
• Serum tryptase: elevated during acute anaphylaxis.
• Thyroid function tests: autoimmune thyroid disease is linked to chronic urticaria.
• Specific IgE or skin prick testing: to identify food or environmental allergens.
• Auto‑antibody panels: for chronic spontaneous urticaria (e.g., anti‑FcεRI antibodies).

4. Challenge Tests (performed by specialists)

• Physical provocation tests – cold, heat, pressure, or exercise.
• Oral food or drug challenges under medical supervision.

In many cases of acute urticaria, extensive testing is unnecessary; symptomatic treatment is started while monitoring for improvement.

Treatment Options

Therapy is aimed at two goals: rapid relief of itching and swelling, and prevention of future episodes.

1. Pharmacologic Treatments

• Second‑generation H1 antihistamines: cetirizine, loratadine, fexofenadine, desloratadine. They are non‑sedating and first‑line for both acute and chronic urticaria (Mayo Clinic, 2023).
• First‑generation antihistamines: diphenhydramine or hydroxyzine can be used at night for severe itching, but cause drowsiness.
• Up‑titration: If standard doses are insufficient, guidelines allow increasing to 2–4 times the usual dose under physician supervision.
• H2 antagonists: ranitidine or famotidine can be added for refractory cases (often combined with H1 blockers).
• Leukotriene receptor antagonists: montelukast may help especially when NSAIDs trigger hives.
• Systemic corticosteroids: short courses (e.g., prednisone 10‑20 mg daily for ≤ 1 week) for severe acute flares; long‑term use is avoided due to side effects.
• Biologic therapy: omalizumab (anti‑IgE) is FDA‑approved for chronic spontaneous urticaria refractory to antihistamines (NIH, 2022).
• Immunosuppressants: cyclosporine or methotrexate for rare, refractory chronic cases.

2. Home & Lifestyle Measures

• Apply cool compresses (10‑15 minutes) to reduce itch and swelling.
• Take lukewarm (not hot) baths with colloidal oatmeal or baking soda.
• Avoid known triggers: keep a food and medication diary.
• Wear loose, breathable clothing to prevent friction.
• Use fragrance‑free, dye‑free moisturizers to maintain skin barrier.
• Stress‑reduction techniques – mindfulness, yoga, or regular exercise – can lessen flare‑ups.

3. When to Use Epinephrine

If wheals are accompanied by signs of anaphylaxis (e.g., throat swelling, difficulty breathing, hypotension), administer an auto‑injectable epinephrine (0.3 mg IM for adults) immediately and call emergency services.

Prevention Tips

While not all episodes are preventable, many strategies reduce the likelihood of recurrence:

• Identify and avoid triggers: keep a detailed log of foods, medications, activities, and environmental exposures preceding a flare.
• Read medication labels: watch for hidden NSAIDs, dyes, or preservatives.
• Vaccination awareness: discuss any prior vaccine‑related hives with your provider; they may pre‑medicate with antihistamines.
• Temperature control: for cold or heat urticaria, wear appropriate protective clothing and avoid extreme temperature changes.
• Skin care: moisturize daily, avoid harsh soaps, and use gentle, hypoallergenic detergents.
• Stress management: regular relaxation practice can lower mast‑cell activation.
• Regular follow‑up: for chronic urticaria, periodic review with an allergist or dermatologist helps adjust therapy and monitor for underlying disease.

Emergency Warning Signs

Key Take‑aways

Wheals (urticaria) are a common, often benign skin reaction that can range from a fleeting annoyance to a sign of a serious allergic reaction. Prompt identification of triggers, appropriate antihistamine therapy, and awareness of warning signs are essential for safe management. When hives persist beyond a few weeks, are resistant to standard treatment, or are accompanied by systemic symptoms, professional evaluation is crucial to rule out chronic or systemic causes.

References:

• Mayo Clinic. “Urticaria (Hives).” 2023. https://www.mayoclinic.org
• American Academy of Dermatology. “Urticaria (Hives) Overview.” 2022.
• National Institute of Allergy and Infectious Diseases (NIAID). “Guidelines for the Management of Chronic Urticaria.” 2022.
• World Health Organization. “Allergic Reactions and Anaphylaxis.” 2021.
• Cleveland Clinic. “Omalizumab for Chronic Spontaneous Urticaria.” 2023.
• Centers for Disease Control and Prevention (CDC). “Anaphylaxis – What You Need to Know.” 2023.

```